亿元！广东国企，投了一家生物制造！
Ranking
No observed public metrics; popularity remains neutral/archived.
Merged summary
TL;DR - Microalgae biomanufacturing startup 元育生物 (Yuanyu Bio) closed a RMB 100M A+ round funded solely by Guangdong Salt Industry Group, a provincial SOE. It signals state-backed capital flowing into synthetic-biology/biomanufacturing platforms rather than AI models per se.
- Founded 2021 with a core team out of Tsinghua University; positions microalgae as a platform "biological chassis" spanning cosmetics and food.
- Two product lines: non-animal-derived active delivery systems (microalgal extracellular vesicles, MEVs) for beauty, and novel microalgal protein for food.
- Claimed traction: exclusive MEV supply-chain deal with a top global cosmetics group, and national New Food Ingredient approval for a yellow protein Chlorella strain.
- Proceeds mainly fund a standardized MEV manufacturing base (construction already started), extending its Algsis brand beyond algae to microbial and higher-plant vesicle sources (Chlorella, Euglena, Chlamydomonas, lactic acid bacteria, yeast).
Note: the source is a short WeChat news post with no technical data or AI methodology — takeaways are limited to the funding and commercialization claims stated.
Sources (1)
亿元！广东国企，投了一家生物制造！
TL;DR - Microalgae biomanufacturing startup 元育生物 (Yuanyu Bio) closed a RMB 100M A+ round funded solely by Guangdong Salt Industry Group, a provincial SOE. It signals state-backed capital flowing into synthetic-biology/biomanufacturing platforms rather than AI models per se.
- Founded 2021 with a core team out of Tsinghua University; positions microalgae as a platform "biological chassis" spanning cosmetics and food.
- Two product lines: non-animal-derived active delivery systems (microalgal extracellular vesicles, MEVs) for beauty, and novel microalgal protein for food.
- Claimed traction: exclusive MEV supply-chain deal with a top global cosmetics group, and national New Food Ingredient approval for a yellow protein Chlorella strain.
- Proceeds mainly fund a standardized MEV manufacturing base (construction already started), extending its Algsis brand beyond algae to microbial and higher-plant vesicle sources (Chlorella, Euglena, Chlamydomonas, lactic acid bacteria, yeast).
Note: the source is a short WeChat news post with no technical data or AI methodology — takeaways are limited to the funding and commercialization claims stated.